Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $26.9900 (-3.3%) ($26.7500 - $28.2000) on Tue. Feb. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.26% (three month average) | RSI | 36 | Latest Price | $26.9900(-3.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.63% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-3%) TBT(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.63% (StdDev 3.26%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
Resistance Level | $28.7 | 5 Day Moving Average | $27.59(-2.17%) | 10 Day Moving Average | $27.46(-1.71%) | 20 Day Moving Average | $28.7(-5.96%) | To recent high | -17.7% | To recent low | 32.4% | Market Cap | $1.676b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |